Combining in silico tools and NMR data to validate protein-ligand structural models: Application to matrix metalloproteinases

被引:40
作者
Bertini, I
Fragai, M
Giachetti, A
Luchinat, C
Maletta, M
Parigi, G
Yeo, KJ
机构
[1] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy
[2] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy
[3] Univ Florence, Dept Agr Biotechnol, I-50144 Florence, Italy
[4] ProtEra, I-50019 Sesto Fiorentino, Italy
关键词
D O I
10.1021/jm050574k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A combination of in silico tools and experimental NMR data is proposed for relatively fast determination of protein-ligand structural models and demonstrated from known inhibitors of matrix metalloproteinases (MMP). The N-15 H-1 heteronuclear single quantum coherence (HSQC) spectral assignment and the 3D structure, either X-ray or NMR, are needed. In this method, the HSQC spectrum with or without the ligand is used to determine the interaction region of the ligand. Docking calculations are then performed to obtain a set of structural models. From the latter, the nuclear Overhauser effects (NOEs) between the ligand and the protein can be predicted. Guided by these predictions, a number of NOEs can be detected and assigned through a HSQC NOESY experiment. These data are used as structural restraints to reject/ refine the initial structural models through further in silico work. For a test protein (MMP-12, human macrophage metalloelastase), a final structure of a protein-ligand adduct was obtained that matches well with the full structural determination. A number of structural predictions were then made for adducts of a similar protein (MMP-1, human fibroblast collagenase) with the same and different ligands. The quality of the final results depended on the type and number of experimental NOEs, but in all cases, a well-defined ligand conformation in the protein binding site was obtained. This protocol is proposed as a viable alternative to the many approaches described in the literature.
引用
收藏
页码:7544 / 7559
页数:16
相关论文
共 59 条
[1]   The process of structure-based drug design [J].
Anderson, AC .
CHEMISTRY & BIOLOGY, 2003, 10 (09) :787-797
[2]   Paramagnetism-based restraints for Xplor-NIH [J].
Banci, L ;
Bertini, I ;
Cavallaro, G ;
Giachetti, A ;
Luchinat, C ;
Parigi, G .
JOURNAL OF BIOMOLECULAR NMR, 2004, 28 (03) :249-261
[3]  
Bartram ME, 2000, MRS INTERNET J N S R, V5, P1
[4]   X-ray structures of binary and ternary enzyme-product-Inhibitor complexes of matrix metalloproteinases [J].
Bertini, I ;
Calderone, V ;
Fragai, M ;
Luchinat, C ;
Mangani, S ;
Terni, B .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (23) :2673-2676
[5]   Conformational variability of matrix metalloproteinases: Beyond a single 3D structure [J].
Bertini, I ;
Calderone, V ;
Cosenza, M ;
Fragai, M ;
Lee, YM ;
Luchinat, C ;
Mangani, S ;
Terni, B ;
Turano, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (15) :5334-5339
[6]   High-throughput crystallography for lead discovery in drug design [J].
Blundell, TL ;
Jhoti, H ;
Abell, C .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) :45-54
[7]   Protein flexibility and drug design: how to hit a moving target [J].
Carlson, HA .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) :447-452
[8]   Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor [J].
Chen, DZ ;
Patel, DV ;
Hackbarth, CJ ;
Wang, W ;
Dreyer, G ;
Young, DC ;
Margolis, PS ;
Wu, C ;
Ni, ZJ ;
Trias, J ;
White, RJ ;
Yuan, ZY .
BIOCHEMISTRY, 2000, 39 (06) :1256-1262
[9]  
Clendeninn N.J., 2001, METALLOPROTEINASE IN
[10]   Accurate and rapid docking of protein-protein complexes on the basis of intermolecular nuclear Overhauser enhancement data and dipolar couplings by rigid body minimization [J].
Clore, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :9021-9025